CONFIDENTIAL TREATMENT REQUESTED AGREEMENTConfidential Treatment Requested Agreement • September 15th, 2015 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Delaware
This AGREEMENT (“Agreement”) is entered into as of November 22, 2010 (“Effective Date”) by and between ReGenX Biosciences, LLC (formerly known as ReGenX, LLC), a limited liability company organized under the laws of the State of Delaware, with offices at 750 17th Street, NW, Suite 1100, Washington, DC 20006 (“Licensor”), Chatham Therapeutics, LLC, a North Carolina limited liability company with offices at 45 Chatham Parkway, Chapel Hill, NC 27517 (“Licensee”), and, for purposes of Article 10, Asklepios Biopharmaceutical, Inc., a North Carolina corporation with offices at 45 Chatham Parkway, Chapel Hill, NC 27517 (“Guarantor”). Licensor and Licensee are hereinafter referred to individually as a “Party” and collectively as the “Parties.”
AGREEMENTConfidential Treatment Requested Agreement • March 30th, 2001 • Boron Lepore & Associates Inc • Services-business services, nec • New Jersey
EXHIBIT 10.13 CONFIDENTIAL TREATMENT REQUESTED AGREEMENT Effective as of July 1, 1990, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California ("STANFORD"), and PROTEIN...Confidential Treatment Requested Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
EXHIBIT 10.9 CONFIDENTIAL TREATMENT REQUESTED AGREEMENT This Agreement is entered into as of January 31, 1989 ("Effective Date"), by and between F. HOFFMANN-LA ROCHE & CO. LIMITED COMPANY of Basle, Switzerland ("F. Roche) and PROTEIN DESIGN LABS,...Confidential Treatment Requested Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
CONFIDENTIAL TREATMENT REQUESTED AGREEMENTConfidential Treatment Requested Agreement • March 20th, 2014 • Histogenics Corp • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
where $x is the additional amount of equity investment beyond the $**** contemplated by the **** Term Sheet. The Consideration shall be paid from the net proceeds to be received by the Histogenics’ stockholders after the payment of; (a) transaction costs to unaffiliated third parties, (b) repayment of debt incurred after the Effective Date, if any, and (c) the payment of all rights and
EXHIBIT 10.8 CONFIDENTIAL TREATMENT REQUESTED AGREEMENT This Agreement is entered into as of January 31, 1989 ("Effective Date"), by and between HOFFMANN-LA ROCHE INC., a New Jersey corporation having offices at 340 Kingsland Street, Nutley, New...Confidential Treatment Requested Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
CONFIDENTIAL TREATMENT REQUESTED AGREEMENTConfidential Treatment Requested Agreement • October 7th, 2014 • Histogenics Corp • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
Agreement made and entered into as of the 22nd day of June, 2012, by and between Purpose Co., Ltd., f/k/a Takagi Sangyo Co. Ltd., and also f/k/a Takagi Industrial Co., Ltd., a Japanese corporation (“Takagi”), and Histogenics Corporation, a Delaware corporation (“Histogenics”) (the “Agreement”). The parties agree as follows:
